After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

NeuroSolve is a four-year project funded by the European Commission and EDCTP3, started on May 1, 2023. The African Institutions involved are: University of Dar es Salaam (Tanzania), Sokoine University of Agriculture (Tanzania), University of Zambia (Zambia); the European Institutions are: Universiteit Ghent (Belgium) and R-Evolution Worldwide Srl – Impresa Sociale (Italy), that is also the project Coordinator. NeuroSolve is committed to fight taeniasis/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.

Potrebbe essere un'immagine raffigurante testo

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

STRIDE-Africa: strengthening ethics, regulation, and pharmacovigilance through digital innovation and responsible AI

We are pleased to announce the submission of STRIDE-Africa project to the European Commission under the Global Health EDCTP3 programme. The project STRIDE-Africa (African-led Training and Innovation Networks for Sustained

Read More

TB-SHIELD-WOMEN Proposal submitted to EDCTP3 call for innovative TB treatment research in sub-Saharan Africa

Our organization, together with an international consortium of partners, has submitted the project TB-SHIELD-WOMEN – Supportive nutritional Health Intervention for Enhanced recovery and Lowered Drug toxicity in vulnerable groups of

Read More

PREPARE: Strengthening Regulatory, Ethics, and Pharmacovigilance Systems for Health Preparedness in Sub-Saharan Africa

PREPARE – Pharmacovigilance, Regulatory and Ethics Preparedness and Response Innovation Network – is one of the newest proposal that we submitted to the European Commission under the Global Health EDCTP3 programme.

Read More